Intuitive Surgical, Inc. stock (US46120E6023): shares under pressure after recall-linked slide

Intuitive Surgical, Inc. shares on Nasdaq remained under pressure on 05/28/2026 after a recall-driven drop of around 3–4% the previous session, keeping the US-based robotic surgery leader well below recent 52-week highs.

Intuitive Surgical, Inc. shares continued to trade weakly on the Nasdaq in the United States on 05/28/2026, after the stock fell about 3.3% on 05/27/2026, with one market-mover report citing significant product recalls affecting its core da Vinci robotic surgery systems as a key driver of the move, according to TradingKey as of 05/27/2026.

Data from GuruFocus on 05/27/2026 indicated that Intuitive Surgical closed that session at USD 418.55, down 4.1% on the day and within a 52-week range of USD 414.30 to USD 603.88, underscoring how far the stock currently trades below its recent peak levels.

As of 05/28/2026, Robinhood showed Intuitive Surgical trading around USD 419.86–419.91 on Nasdaq under the ticker ISRG, implying a market capitalization of roughly USD 148.2 billion and a price-to-earnings ratio in the low-50s, reinforcing the company’s status as a large-cap US medical technology name.

The stock’s recent weakness keeps it well shy of valuation benchmarks used by some third-party models, with GuruFocus estimating a GF Value metric of USD 593.81 for Intuitive Surgical as of 05/27/2026, almost 30% above the then-prevailing share price of USD 418.55, although this is an external assessment and not formal guidance from the company.

For investors in Germany, the shares are also available via local trading venues such as Tradegate, where Intuitive Surgical typically trades in euros based on the underlying Nasdaq price, providing an additional access route beyond the primary US listing for European retail investors.

The stock traded at USD 418.55 on 05/27/2026 on Nasdaq, according to GuruFocus as of 05/27/2026, while recent intraday data around USD 419.9 and a market capitalization near USD 148.2 billion were reported by Robinhood as of 05/28/2026.

As of: 05/28/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Intuitive Surgical
• Sector/industry: Medical technology, robotic-assisted surgery
• Headquarters/country: Sunnyvale, United States
• Core markets: Hospitals and surgical centers in the United States, Europe and Asia-Pacific
• Key revenue drivers: Sales and placements of da Vinci surgical systems, recurring instrument and accessory usage, and service contracts
• Home exchange/listing venue: Nasdaq (ISRG)
• Trading currency: USD

Intuitive Surgical, Inc.: core business model

Intuitive Surgical focuses on robotic-assisted surgical platforms, with revenue primarily generated from a growing installed base of da Vinci systems that drives ongoing demand for disposable instruments, accessories and maintenance services.

Industry trends and competitive position

The global market for robotic-assisted surgery has expanded steadily in recent years as hospitals aim to reduce complication rates, shorten patient recovery times and address surgeon shortages, with research firms such as S&P Global and various medical-technology studies highlighting structural growth in minimally invasive procedures over the medium term.

Within this landscape, Intuitive Surgical has built a leading position in soft-tissue robotic surgery through its da Vinci systems, while facing competition from established medical device companies and new entrants developing rival platforms, which puts a premium on continued innovation, regulatory compliance and product reliability, especially when events such as product recalls temporarily draw attention to operational risks.

Conclusion

The recent decline in Intuitive Surgical, Inc. shares on Nasdaq, linked by some market observers to product recalls affecting the da Vinci surgical platform, has pulled the stock further away from its 52-week high and closer to the lower end of its trading range.

Against this backdrop, the broader industry context of expanding robotic-assisted surgery adoption and Intuitive Surgical’s entrenched competitive position remain key reference points for investors assessing the company’s long-term prospects relative to short-term share price volatility.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.